Target intelligence / Profile preview

CREB-binding protein (CBP) KIX domain (CBP KIX)

Target
CBP KIX
Molecular classification
Transcription coactivator, Protein-protein interaction domain, Epigenetic regulator
01

Overview

The CREB-binding protein (CBP) KIX domain is a highly conserved protein-protein interaction module located within the transcriptional coactivator CBP (UniProt P45481). It serves as a critical docking site for various transcription factors, including CREB, c-Myb, MLL, and p53, thereby facilitating the assembly of the transcriptional machinery at specific gene promoters (PMID: 9342353). By mediating these interactions, the KIX domain plays a pivotal role in regulating gene expression programs involved in cell growth, differentiation, and memory formation. In many cancers, particularly acute myeloid leukemia (AML) and prostate cancer, the KIX domain is exploited by oncogenic transcription factors to drive aberrant gene expression (PMID: 26053138). Consequently, the KIX domain has emerged as a significant therapeutic target for the development of small-molecule inhibitors, such as KG-501, designed to disrupt these protein-protein interactions (PMID: 19158331). These inhibitors aim to block the binding of oncogenic drivers like Myb or MLL, potentially halting cancer progression. However, because CBP is involved in numerous physiological processes, achieving selectivity and avoiding systemic toxicity remain major challenges in drug development. Furthermore, the structural similarity between the KIX domains of CBP and its paralog p300 complicates the design of specific inhibitors.

Other names
CREBBP KIX domainKIX domain of CBPCBP/p300 KIX domain
02

Mechanism of action

Inhibition of protein-protein interactions between the KIX domain and transcription factors such as CREB, Myb, and MLL.

03

Biological functions

Transcriptional regulationSignal transductionCell proliferationCell differentiation
04

Disease associations

CancerAcute myeloid leukemiaProstate cancerRubinstein-Taybi syndrome
05

Safety considerations

Broad transcriptional disruptionPotential toxicity due to pleiotropic effectsRedundancy and cross-reactivity with p300
06

Interacting drugs

KG-501

2 more in the full profile.

07

Biomarkers

CREB-mediated gene expressionMyb-target gene levels

Beyond the preview

Go deeper on CREB-binding protein (CBP) KIX domain (CBP KIX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CREB-binding protein (CBP) KIX domain (CBP KIX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call